zoledronic acid has been researched along with Diabetic Feet in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhansali, A; Das, L; Dutta, P; Jude, EB; Prakash, M; Rastogi, A | 1 |
| Jafer, AK; Yeo, J | 1 |
1 trial(s) available for zoledronic acid and Diabetic Feet
| Article | Year |
|---|---|
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
Topics: Anti-Inflammatory Agents; Arthropathy, Neurogenic; Bone Density; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Female; Humans; Inflammation; Male; Methylprednisolone; Middle Aged; Osteogenesis; Treatment Outcome; Zoledronic Acid | 2021 |
1 other study(ies) available for zoledronic acid and Diabetic Feet
| Article | Year |
|---|---|
Zolendronate associated inflammatory orbital disease.
Topics: Bone Density Conservation Agents; Diabetic Foot; Diagnosis, Differential; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Orbital Diseases; Zoledronic Acid | 2010 |